Global X HealthTech ETF (NASDAQ:HEAL) Stock Falls 0.4% – Time to Sell?

Global X HealthTech ETF (NASDAQ:HEAL – Get Free Report)’s share price dropped 0.4% during trading on Thursday. The stock traded as low as $28.70 and last traded at $28.9080. Approximately 2,378 shares traded hands during mid-day trading, a decline of 77% from the average session volume of 10,158 shares. The stock had previously closed at $29.03.

Global X HealthTech ETF Stock Up 2.7%

The business has a 50 day moving average price of $29.18 and a two-hundred day moving average price of $27.01. The stock has a market cap of $31.16 million, a P/E ratio of 42.80 and a beta of 1.13.

Institutional Investors Weigh In On Global X HealthTech ETF

Several institutional investors and hedge funds have recently modified their holdings of the stock. Royal Bank of Canada grew its position in shares of Global X HealthTech ETF by 39.4% during the first quarter. Royal Bank of Canada now owns 2,603 shares of the company’s stock valued at $62,000 after purchasing an additional 736 shares in the last quarter. Farther Finance Advisors LLC lifted its position in shares of Global X HealthTech ETF by 4.3% in the third quarter. Farther Finance Advisors LLC now owns 23,037 shares of the company’s stock worth $680,000 after buying an additional 950 shares in the last quarter. Finally, WT Wealth Management lifted its position in shares of Global X HealthTech ETF by 14.7% in the first quarter. WT Wealth Management now owns 101,116 shares of the company’s stock worth $2,409,000 after buying an additional 12,945 shares in the last quarter.

About Global X HealthTech ETF

(Get Free Report)

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.

Read More

Receive News & Ratings for Global X HealthTech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global X HealthTech ETF and related companies with MarketBeat.com's FREE daily email newsletter.